CMPX250815C00002000 Option on Compass Therapeutics
CMPX Stock | USD 3.07 0.07 2.33% |
CMPX250815C00002000 is a PUT option contract on Compass Therapeutics' common stock with a strick price of 2.0 expiring on 2025-08-15. The contract was not traded in recent days and, as of today, has 23 days remaining before the expiration. The option is currently trading at an ask price of $5.0. The implied volatility as of the 23rd of July is 23.0.
A put option written on Compass Therapeutics becomes more valuable as the price of Compass Therapeutics drops. Conversely, Compass Therapeutics' put option loses its value as Compass Stock rises.
Rule 16 of 2025-08-15 Option Contract
The options market is anticipating that Compass Therapeutics will have an average daily up or down price movement of about 0.58% per day over the life of the option. With Compass Therapeutics trading at USD 3.07, that is roughly USD 0.0179. If you think that the market is fully understating Compass Therapeutics' daily price movement you should consider buying Compass Therapeutics options at that current volatility level of 9.31%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
In The Money Call Option on Compass Therapeutics
An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Compass Therapeutics positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Compass Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Call Contract Name | CMPX250815C00002000 |
Expires On | 2025-08-15 |
Days Before Expriration | 23 |
Delta | 0.915354 |
Vega | 0.001221 |
Gamma | 0.021166 |
Theoretical Value | 2.5 |
Open Interest | 57 |
Strike Price | 2.0 |
Last Traded At | 1.0 |
Current Price Spread | 0.0 | 5.0 |
Rule 16 Daily Up or Down | USD 0.0179 |
Compass short PUT Option Greeks
Compass Therapeutics' Option Greeks for the contract ending on 2025-08-15 at a strike price of 2.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Compass Therapeutics' option greeks, its implied volatility helps estimate the risk of Compass Therapeutics stock implied by the prices of the options on Compass Therapeutics' stock.
Delta | 0.915354 | |
Gamma | 0.021166 | |
Theta | -0.023727 | |
Vega | 0.001221 | |
Rho | 2.04E-4 |
Compass long PUT Option Payoff at expiration
Put options written on Compass Therapeutics grant holders of the option the right to sell a specified amount of Compass Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Compass Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Compass Therapeutics is like buying insurance aginst Compass Therapeutics' downside shift.
Profit |
Compass Therapeutics Price At Expiration |
Compass short PUT Option Payoff at expiration
By selling Compass Therapeutics' put option, the investors signal their bearish sentiment. A short position in a put option written on Compass Therapeutics will generally make money when the underlying price is above the strike price. Therefore Compass Therapeutics' put payoff at expiration depends on where the Compass Stock price is relative to the put option strike price. The breakeven price of 4.5 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Compass Therapeutics' price. Finally, at the strike price of 2.0, the payoff chart is constant and positive.
Profit |
Compass Therapeutics Price At Expiration |
Compass Therapeutics Available Call Options
Compass Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Compass. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Compass. It also shows strike prices and maturity days for a Compass Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Strike Price | Current Spread | Last Price | |||
Call | CMPX250919C00006000 | 0 | 6.0 | 0.0 - 2.9 | 2.9 | |
Call | CMPX250919C00005000 | 0 | 5.0 | 0.0 - 2.95 | 2.95 | |
Call | CMPX250919C00004000 | 0 | 4.0 | 0.0 - 0.6 | 0.6 | |
Call | CMPX250919C00003000 | 0 | 3.0 | 0.0 - 3.4 | 3.4 | In |
Call | CMPX250919C00002000 | 0 | 2.0 | 0.0 - 4.0 | 4.0 | In |
Call | CMPX250919C00001000 | 0 | 1.0 | 0.1 - 5.0 | 0.1 | In |
Compass Therapeutics Corporate Management
Susan Kalled | Chief Officer | Profile | |
MD MBA | Chief Officer | Profile | |
Barry JD | Chief Officer | Profile | |
Neil CPA | Senior Officer | Profile | |
Peter Moesta | Interim CMC | Profile | |
Anna Gifford | Communications Manager | Profile |
Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.